M, S. K., J. D. Katamreddy, and J. R. P. “A Review on ANDA Submission Requirements for Generic Drugs: ‘Paragraph IV certification’ As Per FDA CDER Guidelines”. International Journal of Drug Regulatory Affairs, Vol. 6, no. 3, Sept. 2018, pp. 5-12, doi:10.22270/ijdra.v6i3.260.